Medico Intercontinental Intrinsic Value
Medico Intercontinental (MIL) median intrinsic value is ₹49.00 from 3 valuation models (range ₹46–₹56), vs current price ₹22.87 — +114.3% upside (Trading Below Calculated Value), margin of safety 53.3%. Also explore Medico Intercontinental stock price data download to track price trends across different timeframes.
MIL Valuation Methods Summary — DCF, Graham Number & P/E
Medico Intercontinental intrinsic value across 3 models vs current price ₹22.87 — upside/downside and value range per method. Browse MIL cash flow statement for revenue, profit, balance sheet and cash flow data.
| Method | Type | Intrinsic Value | Range | Upside/Downside | Details |
|---|---|---|---|---|---|
| Book Value Method | asset | ₹49.00 | ₹44.10 - ₹53.90 | +114.3% | Book Value/Share: ₹49.00, P/B: 1.0x |
| Revenue Multiple Method | revenue | ₹45.74 | ₹41.17 - ₹50.31 | +100.0% | Revenue/Share: ₹84.00, P/S: 0.8x |
| Simple DCF (5Y) | dcf | ₹55.70 | ₹44.56 - ₹66.84 | +143.6% | CF Growth: 5.0%, Discount: 15% |
MIL Intrinsic Value vs Market Price — All Valuation Models
Medico Intercontinental fair value range ₹46–₹56 vs current market price ₹22.87 across 3 valuation models. For current market price and key ratios, visit MIL share price.
MIL Intrinsic Value Analysis — Undervalued or Overvalued?
Medico Intercontinental median intrinsic value ₹49.00, current price ₹22.87 — Trading Below Calculated Value by 114.3%, margin of safety 53.3%.
What is the intrinsic value of MIL?
Based on our comprehensive analysis using 3 different valuation methods, the estimated intrinsic value of Medico Intercontinental (MIL) is ₹49.00 (median value). With the current market price of ₹22.87, this represents a +114.3% variance from our estimated fair value.
The valuation range spans from ₹45.74 to ₹55.70, indicating ₹45.74 - ₹55.70.
Is MIL undervalued or overvalued?
Based on our multi-method analysis, Medico Intercontinental (MIL) appears to be trading below calculated value by approximately 114.3%.
MIL Financial Health — Key Ratios vs Industry Benchmarks
Medico Intercontinental financial ratios — ROE, debt-to-equity, profit margins and liquidity vs industry benchmarks and their impact on intrinsic value.
| Financial Metric | Current Value | Industry Benchmark | Assessment | Impact on Valuation |
|---|---|---|---|---|
| Current Ratio | 4.07 | Industry Standard: 2.0+ | Above 2.0 | Measures short-term liquidity capacity |
| Return on Equity | -40.8% | Industry Standard: 15%+ | Below 10% | Measures shareholder return efficiency |
| Operating Margin | -4.0% | Industry Standard: 20%+ | Below 10% | Indicates operational efficiency level |
| Asset Turnover Ratio | 1.11x | Industry Standard: 1.0x+ | Above 1.0x | Measures asset utilization efficiency |
MIL Cash Flow Quality — Operating & Free Cash Flow
Medico Intercontinental operating cash flow, free cash flow, quality rating and sustainability score by period — key inputs to DCF intrinsic value calculation.
| Period | Operating Cash Flow | Free Cash Flow | Cash Flow Quality | Sustainability Score |
|---|---|---|---|---|
| March 2025 | ₹-7 Cr | ₹-8 Cr | Negative Cash Flow | 3/10 |
| March 2024 | ₹6 Cr | ₹2 Cr | Positive Free Cash Flow | 7/10 |
| March 2023 | ₹-10 Cr | ₹-13 Cr | Negative Cash Flow | 3/10 |
| March 2022 | ₹4 Cr | ₹4 Cr | Positive Free Cash Flow | 8/10 |
| March 2021 | ₹6 Cr | ₹6 Cr | Positive Free Cash Flow | 8/10 |